nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case series of B-Lymphoblastic lymphoma with C-MYC rearrangement in children: diagnostic and therapeutic challenges
|
Yang, Xueliang |
|
|
104 |
5 |
p. 3059-3066 |
artikel |
2 |
Alemtuzumab for haematological malignancies
|
An, Ning |
|
|
104 |
5 |
p. 2593-2603 |
artikel |
3 |
A novel compound heterozygous mutation (c.64G > A and c.506-1G > A) associated with congenital coagulation factor VII deficiency: a case report and literature review
|
Jiao, Yu |
|
|
104 |
5 |
p. 2995-3000 |
artikel |
4 |
An unexpected find of multifocal extranodal marginal zone lymphoma
|
Van den Bosch, Glenn |
|
|
104 |
5 |
p. 3029-3034 |
artikel |
5 |
A rare case of type 2A von Willebrand disease with compound heterozygous mutation
|
Wang, Li-jing |
|
|
104 |
5 |
p. 3053-3057 |
artikel |
6 |
Blinatumomab in combination with olverembatinib and concurrent intrathecal chemotherapy successfully treated a chronic myeloid leukemia relapse with central nervous system blast crisis: case report and literature review
|
Wang, Ying |
|
|
104 |
5 |
p. 3047-3051 |
artikel |
7 |
Case report: single-cell transcriptome sequencing reveals the clonal origin of mature plasmacytoid dendritic cell proliferation in early T-cell precursor lymphoblastic leukemia
|
Zhang, Longyi |
|
|
104 |
5 |
p. 2989-2994 |
artikel |
8 |
Clinical characteristics and prognostic factors in patients with fever of unknown origin who developed secondary haemophagocytic lymphohistiocytosis
|
Zhou, Zhe |
|
|
104 |
5 |
p. 2683-2691 |
artikel |
9 |
Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome
|
Kwon, Young Dai |
|
|
104 |
5 |
p. 2693-2706 |
artikel |
10 |
Clinicopathological and prognostic significance of DDX41 mutation in myeloid neoplasms: a systematic review and meta-analysis
|
Miao, Liying |
|
|
104 |
5 |
p. 2581-2591 |
artikel |
11 |
Combination of pre-transplant flow cytometry, WT1 expression, and NGS for MRD monitoring is potent in predicting the prognosis of AML receiving allogeneic transplantation
|
Liu, Jie |
|
|
104 |
5 |
p. 2915-2926 |
artikel |
12 |
CpG can induce the proliferation and differentiation of B10 cells in the peripheral blood of children with immune thrombocytopenic purpura
|
Gu, Shuge |
|
|
104 |
5 |
p. 2671-2681 |
artikel |
13 |
Efficacy and safety analysis of China’s first 10% IVIg (RonsenGlob) therapy in treating adult ITP
|
Fang, Lijun |
|
|
104 |
5 |
p. 2643-2651 |
artikel |
14 |
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study
|
Zhu, Ting |
|
|
104 |
5 |
p. 2745-2753 |
artikel |
15 |
Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis
|
Kilic, Berkay |
|
|
104 |
5 |
p. 2617-2630 |
artikel |
16 |
Epidemiologic sequential analysis of pure red blood cell aplasia and T-cell large granular lymphocyte leukemia in Korea
|
Park, Sooyong |
|
|
104 |
5 |
p. 2881-2887 |
artikel |
17 |
First-line treatment of TAFRO syndrome with rituximab: a case report and literature review
|
Servati, Salar |
|
|
104 |
5 |
p. 3035-3046 |
artikel |
18 |
From severe aplastic anemia with TERT variant to Wilson disease - associations or not
|
Chen, Tong |
|
|
104 |
5 |
p. 3011-3018 |
artikel |
19 |
Genetic polymorphism of novel SNP rs5006884 in OR51B6 and SNP rs4499252 in AHSP among transfusion-dependent and non-transfusion-dependent β-thalassemia/Hb E patients in Thailand: a multivariate analysis of clinical and genetic polymorphism
|
Mahabhol, Chidchanok |
|
|
104 |
5 |
p. 2653-2661 |
artikel |
20 |
GPVI-dependent functional competence of buffy coat platelet concentrates (PCs) versus PRP-derived PCs: insights into the effects of biomechanical forces during platelet preparation
|
Hosseini, Ehteramolsadat |
|
|
104 |
5 |
p. 2973-2988 |
artikel |
21 |
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial
|
Dührsen, Ulrich |
|
|
104 |
5 |
p. 2831-2845 |
artikel |
22 |
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study
|
Fu, Weijun |
|
|
104 |
5 |
p. 2765-2776 |
artikel |
23 |
Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes
|
Zhang, Jie |
|
|
104 |
5 |
p. 2847-2867 |
artikel |
24 |
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myeloma
|
Enssle, Julius C. |
|
|
104 |
5 |
p. 2813-2821 |
artikel |
25 |
Impact of BCOR/BCORL1 mutation on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients
|
Zhou, YunXia |
|
|
104 |
5 |
p. 2631-2642 |
artikel |
26 |
Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis type
|
Yokoyama, Hisayuki |
|
|
104 |
5 |
p. 2905-2913 |
artikel |
27 |
Incidence and risk factors of severe infections in diffuse large B-cell lymphoma patients undergoing immunochemotherapy
|
Zhao, Haiqiu |
|
|
104 |
5 |
p. 2869-2879 |
artikel |
28 |
Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials
|
Mahadevia, Himil |
|
|
104 |
5 |
p. 2605-2616 |
artikel |
29 |
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
|
Fianchi, Luana |
|
|
104 |
5 |
p. 2731-2736 |
artikel |
30 |
Molecular analysis of T-cell Acute Lymphoblastic Leukemia arising after Essential Thrombocythemia foreshadows a distinct clonal route for lymphoid blast crisis in Philadelphia-negative chronic myeloproliferative neoplasm: a case report with literary review
|
Grimaldi, Francesco |
|
|
104 |
5 |
p. 2897-2904 |
artikel |
31 |
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis
|
Morath, Olga |
|
|
104 |
5 |
p. 2755-2763 |
artikel |
32 |
Molecular response with asciminib 20 mg QD in a patient intolerant to multiple TKIs
|
Stuckey, Ruth |
|
|
104 |
5 |
p. 3007-3009 |
artikel |
33 |
Multiplex digital PCR enables sensitive detection of resistance to BTK inhibitors
|
Garcia, Manon |
|
|
104 |
5 |
p. 2889-2895 |
artikel |
34 |
Multisystem Langerhans cell histiocytosis in a pediatric patient: a rare case report with literature review and future directions
|
Hanifa, Hamdah |
|
|
104 |
5 |
p. 3067-3072 |
artikel |
35 |
Optimising survivorship post-BMT: healthcare professionals’ perceptions of long-term care
|
McErlean, Gemma |
|
|
104 |
5 |
p. 2927-2935 |
artikel |
36 |
Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study
|
Zheng, Wenshuai |
|
|
104 |
5 |
p. 2799-2811 |
artikel |
37 |
Paraneoplastic leukocytoclastic vasculitis mimicking ulcus cruris as rare initial manifestation of smoldering myeloma IgG kappa
|
Brummer, Christina |
|
|
104 |
5 |
p. 3019-3027 |
artikel |
38 |
Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia
|
Turkina, Anna |
|
|
104 |
5 |
p. 2707-2715 |
artikel |
39 |
Platelet-to-Neutrophil ratio as a predictor of risk of complications in sickle cell disease: a valuable insight for resource-limited settings
|
Efobi, Chilota |
|
|
104 |
5 |
p. 2663-2669 |
artikel |
40 |
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL
|
Ren, Yuhong |
|
|
104 |
5 |
p. 2823-2830 |
artikel |
41 |
Prognostic role of interim PET-CT demonstrating partial metabolic response in diffuse large B-Cell lymphoma: a retrospective study
|
Gao, Jinjie |
|
|
104 |
5 |
p. 2777-2786 |
artikel |
42 |
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia
|
Sammartano, Vincenzo |
|
|
104 |
5 |
p. 2737-2743 |
artikel |
43 |
Radiotherapy alone with curative intent in a case of limited-stage extranodal NK/T-cell lymphoma nasal type: a case report and review of the literature
|
Mandelli, Biancamaria |
|
|
104 |
5 |
p. 3001-3006 |
artikel |
44 |
Real-world data on the use of subcutaneous daratumumab plus bortezomib, thalidomide, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma
|
Hungria, Vania |
|
|
104 |
5 |
p. 2787-2798 |
artikel |
45 |
Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia with myelodysplasia-related gene mutations under low-intensity therapy
|
Lin, Jinya |
|
|
104 |
5 |
p. 2717-2729 |
artikel |
46 |
Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry
|
Storck, Anthea |
|
|
104 |
5 |
p. 2937-2946 |
artikel |
47 |
Understanding gut Microbiome changes in Korean children, adolescents, and young adults with hematologic malignancies
|
Park, Meerim |
|
|
104 |
5 |
p. 2947-2961 |
artikel |
48 |
Venous thromboembolic risk in hematological hospitalized patients: a retrospective study
|
Cordella, Stefano |
|
|
104 |
5 |
p. 2963-2971 |
artikel |
49 |
What are the most important quality of life domains for patients with aplastic anemia and paroxysmal nocturnal hemoglobinuria?
|
Taylor, Katherine J. |
|
|
104 |
5 |
p. 3073-3075 |
artikel |